Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.
Factor IX – Pipeline Insights, 2015
Published Date: September 30 2015
Geographical Coverage: Global
Report URL: http://ema...
Factor IX – Pipeline Insights, 2015
Factor IX pipeline report provides a complete pipeline
intelligence and understanding ...
Factor IX Pipeline Insights 2015 Report covers the Factor
IX pipeline molecules at various stages of development like
Pre-...
Scope of the report
– This report provides a Factor IX Landscape across the globe
– The report provides drug profiles whic...
Reasons to buy the report
– Complete Pipeline intelligence and complete understanding over
therapeutics development for Fa...
Major points from Table Of Contents for the Factor IX
pipeline report include:
• Factor IX Overview
• Factor IX Pipeline T...
Major points from Table Of Contents for the Gout pipeline report
include:
• Comparative Analysis
• Drug Candidate Profiles...
For more information,
contact us at
sales@emarketorg.com
© emarketorg.com sales@emarketorg.com
Factor IX – Pipeline Insigh...
Nächste SlideShare
Wird geladen in …5
×

Factor IX Pipeline Extensive Therapeutics Analysis and Evaluation Report 2015

146 Aufrufe

Veröffentlicht am

Factor IX pipeline Report provides Factor IX related extensive therapeutic assessments by molecule type, route of administration, monotherapy and combination products.

Veröffentlicht in: Gesundheitswesen
  • Loggen Sie sich ein, um Kommentare anzuzeigen.

  • Gehören Sie zu den Ersten, denen das gefällt!

Factor IX Pipeline Extensive Therapeutics Analysis and Evaluation Report 2015

  1. 1. Factor IX – Pipeline Insights, 2015 Published Date: September 30 2015 Geographical Coverage: Global Report URL: http://emarketorg.com/pro/factor- ix-pipeline-insights-2015/ © emarketorg.com sales@emarketorg.com
  2. 2. Factor IX – Pipeline Insights, 2015 Factor IX pipeline report provides a complete pipeline intelligence and understanding of therapeutics development for Factor IX on the basis of target, MOA, route of administration, technology involved and molecule type. This 2015 Factor IX Pipeline Insights research provides the in-depth analysis of the pipeline assets across the Factor IX. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Factor IX Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. © emarketorg.com sales@emarketorg.com
  3. 3. Factor IX Pipeline Insights 2015 Report covers the Factor IX pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Factor IX related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Factor IX. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Buy a copy of this research at http://emarketorg.com/pro/factor-ix-pipeline- insights-2015/ © emarketorg.com sales@emarketorg.com Factor IX – Pipeline Insights, 2015
  4. 4. Scope of the report – This report provides a Factor IX Landscape across the globe – The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information – Coverage of the Factor IX pipeline on the basis of target, MOA, route of administration, technology involved and molecule type – The report reviews key players involved in the therapeutics development for Factor IX and also provide company profiling – Pipeline products coverage based on various stages of development from NDA filings to discovery. – Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type. © emarketorg.com sales@emarketorg.com Buy a copy of this research at http://emarketorg.com/pro/factor-ix-pipeline-insights-2015/ Factor IX – Pipeline Insights, 2015
  5. 5. Reasons to buy the report – Complete Pipeline intelligence and complete understanding over therapeutics development for Factor IX – Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine. – Track your competitors and develop strategic initiatives to support your drug development activities. – Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business. – Understand the market and choose right partners for in-licensing and out licensing for your valuable assets – Understand the factors behind failed/discontinued projects and move ahead without leaving any stone unturned © emarketorg.com sales@emarketorg.com Buy a copy of this research at http://emarketorg.com/pro/factor-ix-pipeline-insights-2015/ Factor IX – Pipeline Insights, 2015
  6. 6. Major points from Table Of Contents for the Factor IX pipeline report include: • Factor IX Overview • Factor IX Pipeline Therapeutics • Factor IX Therapeutics under Development by Companies • Factor IX Late Stage Products (Filed and Phase III) • Comparative Analysis • Factor IX Mid Clinical Stage Products (Phase II) • Comparative Analysis • Factor IX Early Clinical Stage Products (Phase I and IND Filed) • Comparative Analysis • Factor IX Discovery and Pre-Clinical Stage Products. Factor IX – Pipeline Insights, 2015 © emarketorg.com sales@emarketorg.com
  7. 7. Major points from Table Of Contents for the Gout pipeline report include: • Comparative Analysis • Drug Candidate Profiles Factor IX – Therapeutics Assessment • Assessment by Monotherapy Products • Assessment by Combination Products • Assessment by Route of Administration • Assessment by Molecule Type • Factor IX – Discontinued Products • Factor IX – Dormant Products • Companies Involved in Therapeutics Development for Factor IX • Appendix • Methodology • Contact Us • Disclaimer 17 tables and 12 figures are a part of this report. © emarketorg.com sales@emarketorg.com Factor IX – Pipeline Insights, 2015
  8. 8. For more information, contact us at sales@emarketorg.com © emarketorg.com sales@emarketorg.com Factor IX – Pipeline Insights, 2015

×